Xeris Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Celltrion KRW 829.07B 829.07B 2025-03
Cspc Pharmaceutical 6.78B 1.6B 2024-12
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Eli Lilly USD 3.38B 282.6M 2025-06
Kangmei Pharma CNY 894.14M 120.63M 2025-03
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.62M 7.88M 2024-12
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Pacira USD 300.48M 16.87M 2025-06
Perrigo USD 454.2M 44.3M 2025-06
Pharma Mar EUR 21.59M 38.7M 2025-06
Qiagen NV USD 733.82M 95.06M 2025-06
Sartorius EUR 819M 20.5M 2025-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
Tilray USD 189.7M 15.49M 2024-11
Zz Pientze Pharmaceu 1.39B 93.82M 2025-03


Xeris Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.